Physician profile
Sara S Vannortwick
NPI 1952657827
$35,393.85
in general payments reported to CMS, 2019-2025
8 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,518 · 2020: $17.26 · 2021: $293 · 2023: $137 · 2024: $32K · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $2,558 · Food and Beverage: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,800.00 |
| Travel and Lodging | $2,557.96 |
| Food and Beverage | $1,207.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,274.72 | 2023-2024 | Cd Horizon Spinal System, Synchromedii, Unid_pass |
| Stryker Corporation | $1,637.73 | 2019-2021 | |
| Peerless Surgical INC. | $1,109.00 | 2019 | |
| Trimed, INC. | $141.63 | 2024 | |
| Medical Device Business Services, INC. | $100.72 | 2025 | Attune |
| Orthopediatrics Corp. | $48.28 | 2025 | |
| Allergan, INC. | $41.23 | 2019 | |
| Biomarin Pharmaceutical INC. | $40.54 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Vannortwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.